JPWO2023087009A5 - - Google Patents
Info
- Publication number
- JPWO2023087009A5 JPWO2023087009A5 JP2024527628A JP2024527628A JPWO2023087009A5 JP WO2023087009 A5 JPWO2023087009 A5 JP WO2023087009A5 JP 2024527628 A JP2024527628 A JP 2024527628A JP 2024527628 A JP2024527628 A JP 2024527628A JP WO2023087009 A5 JPWO2023087009 A5 JP WO2023087009A5
- Authority
- JP
- Japan
- Prior art keywords
- tils
- fold
- nucleic acid
- acid encoding
- cytokine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278447P | 2021-11-11 | 2021-11-11 | |
| US63/278,447 | 2021-11-11 | ||
| PCT/US2022/079843 WO2023087009A1 (en) | 2021-11-11 | 2022-11-14 | Methods to generate enhanced tumor infiltrating lymphocytes through microfluidic delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024545582A JP2024545582A (ja) | 2024-12-10 |
| JP2024545582A5 JP2024545582A5 (https=) | 2025-11-21 |
| JPWO2023087009A5 true JPWO2023087009A5 (https=) | 2025-11-21 |
Family
ID=84569474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527628A Pending JP2024545582A (ja) | 2021-11-11 | 2022-11-14 | マイクロ流体送達による増強された腫瘍浸潤リンパ球を作製する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250043244A1 (https=) |
| EP (1) | EP4430168A1 (https=) |
| JP (1) | JP2024545582A (https=) |
| CN (1) | CN118510888A (https=) |
| WO (1) | WO2023087009A1 (https=) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107058101B (zh) | 2011-10-17 | 2021-06-01 | 麻省理工学院 | 细胞内传递 |
| EP3033184B1 (en) | 2013-08-16 | 2021-03-31 | Massachusetts Institute of Technology | Selective delivery of material to cells |
| JP7523203B2 (ja) | 2014-10-31 | 2024-07-26 | マサチューセッツ インスティテュート オブ テクノロジー | 生体分子の免疫細胞への送達 |
| SG10201912910PA (en) | 2015-07-09 | 2020-02-27 | Massachusetts Inst Technology | Delivery of materials to anucleate cells |
| ES2930017T3 (es) | 2015-09-04 | 2022-12-05 | Sqz Biotechnologies Co | Suministro intracelular de biomoléculas mediado por una superficie con poros |
| JP7602702B2 (ja) | 2016-05-03 | 2024-12-19 | ステムセル テクノロジーズ カナダ インコーポレーテッド | 寛容性を誘導するための生体分子の細胞内送達 |
| KR102490952B1 (ko) | 2016-05-03 | 2023-01-19 | 에스큐지 바이오테크놀로지스 컴퍼니 | 관용을 유도하는 생체분자의 세포내 전달 |
| EP3765068A2 (en) | 2018-03-12 | 2021-01-20 | SQZ Biotechnologies Company | Intracellular delivery of biomolecules to modify immune response |
| US12599656B2 (en) | 2018-03-12 | 2026-04-14 | Stemcell Technologies Canada Inc. | Methods for treating HPV-associated diseases |
| KR20210070338A (ko) | 2018-10-04 | 2021-06-14 | 에스큐지 바이오테크놀로지스 컴퍼니 | 항원 제시 세포 기능을 증진시키기 위한 생체분자의 세포내 전달 |
| WO2020154696A1 (en) | 2019-01-25 | 2020-07-30 | Sqz Biotechnologies Company | Anucleate cell-derived vaccines |
| CA3131701A1 (en) | 2019-02-28 | 2020-09-03 | Sqz Biotechnologies Company | Delivery of biomolecules to pbmcs to modify an immune response |
| CA3150224A1 (en) * | 2019-09-10 | 2021-03-18 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
| AU2020355025A1 (en) * | 2019-09-23 | 2022-04-07 | Regents Of The University Of Minnesota | Genetically-edited immune cells and methods of therapy |
| TW202241508A (zh) * | 2021-01-29 | 2022-11-01 | 美商艾歐凡斯生物治療公司 | 細胞介素相關之腫瘤浸潤性淋巴球組合物及方法 |
| WO2023010090A1 (en) * | 2021-07-29 | 2023-02-02 | Sqz Biotechnologies Company | Methods to generate enhanced tumor infiltrating lymphocytes through microfluidic delivery |
-
2022
- 2022-11-14 WO PCT/US2022/079843 patent/WO2023087009A1/en not_active Ceased
- 2022-11-14 EP EP22829633.1A patent/EP4430168A1/en active Pending
- 2022-11-14 JP JP2024527628A patent/JP2024545582A/ja active Pending
- 2022-11-14 US US18/709,331 patent/US20250043244A1/en active Pending
- 2022-11-14 CN CN202280088123.8A patent/CN118510888A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jarrell et al. | Intracellular delivery of mRNA to human primary T cells with microfluidic vortex shedding | |
| Langenkamp et al. | Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells | |
| Niwa et al. | Concentration of extracellular L-glutamate released from cultured nerve cells measured with a small-volume online sensor | |
| Segal et al. | Regulation of heat-shock response in bacteria. | |
| Zhang et al. | Molecularly imprinted polymers with DNA aptamer fragments as macromonomers | |
| US20220081728A1 (en) | Methods of detecting spatial heterogeneity of a biological sample | |
| US8110351B2 (en) | Method for isolating nucleic acids and protein from a single sample | |
| Fu et al. | Threonine aldolase immobilization on different supports for engineering of productive, cost-efficient enzymatic microreactors | |
| Wang et al. | Integrating bulk and single-cell sequencing reveals the phenotype-associated cell subpopulations in sepsis-induced acute lung injury | |
| Shepherd et al. | Cytoplasmic RNA polymerase in Escherichia coli | |
| Kalil et al. | Ion exchange expanded bed chromatography for the purification of an extracelular inulinase from Kluyveromyces marxianus | |
| Bogaert et al. | Inflammatory signatures for eosinophilic vs. neutrophilic allergic pulmonary inflammation reveal critical regulatory checkpoints | |
| Lee et al. | Effect of pore diffusion limitation on dextrin hydrolysis by immobilized glucoamylase | |
| JPWO2023087009A5 (https=) | ||
| SE423718B (sv) | Samtidigt immobiliserade enzym(er) och mikroorganism(er) och deras framstellning | |
| Hegazy et al. | Plasticity and lineage commitment of individual TH1 cells are determined by stable T-bet expression quantities | |
| Grutza et al. | NKG2Cpos NK cells regulate the expansion of cytomegalovirus-specific CD8 T cells | |
| Fong et al. | A serum-and feeder-free system to generate CD4 and regulatory T cells from human iPSCs | |
| Cheekatla et al. | IL-21 receptor signaling is essential for optimal CD4+ T cell function and control of Mycobacterium tuberculosis infection in mice | |
| Willoughby et al. | Immobilised metal ion affinity chromatography purification of alcohol dehydrogenase from baker’s yeast using an expanded bed adsorption system | |
| Klimpel et al. | Perfusion process intensification for lentivirus production using a novel scale‐down model | |
| Mustafa et al. | Secretome profiling with antibody microarrays | |
| Chatterjee et al. | RNA isolation from mammalian cells using porous polymer monoliths: an approach for high-throughput automation | |
| Hasegawa et al. | CC chemokine ligand 2 and leukemia inhibitory factor cooperatively promote pluripotency in mouse induced pluripotent cells | |
| Braghiroli et al. | Regulation of α2-macroglobulin expression in rat Sertoli cells and hepatocytes by germ cells in vitro |